SCHEDULE 13D

Company

Traws Pharma, Inc.

Filed

September 23, 2024

Accession Number

0000947871-24-000770

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →